These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18425066)

  • 1. Myopathic ptosis following posterior sub-Tenon's triamcinolone acetonide injection.
    Morley AM; Tumuluri K; Meligonis G; Collin JR
    Eye (Lond); 2009 Mar; 23(3):741-2. PubMed ID: 18425066
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ptosis and orbital fat prolapse after posterior sub-Tenon's capsule triamcinolone injection.
    Dal Canto AJ; Downs-Kelly E; Perry JD
    Ophthalmology; 2005 Jun; 112(6):1092-7. PubMed ID: 15885781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ptosis after sub-Tenon's capsule triamcinolone.
    Ideta S; Noda M; Kawamura R; Shinoda K; Inoue M; Tsubota K
    Ophthalmology; 2008 Feb; 115(2):410-410.e1. PubMed ID: 18243907
    [No Abstract]   [Full Text] [Related]  

  • 5. Ptosis following an intravitreal injection of triamcinolone acetonide.
    Viola F; Morescalchi F; Ratiglia R; Staurenghi G
    Eye (Lond); 2007 Mar; 21(3):421-3. PubMed ID: 16498434
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.
    Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
    Kawaji T; Takano A; Inomata Y; Sagara N; Iwao K; Inatani M; Fukushima M; Tanihara H
    Br J Ophthalmol; 2008 Jan; 92(1):81-3. PubMed ID: 17965103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single intraoperative sub-Tenon's capsule triamcinolone acetonide injection for the treatment of post-cataract surgery inflammation.
    Paganelli F; Cardillo JA; Melo LA; Oliveira AG; Skaf M; Costa RA;
    Ophthalmology; 2004 Nov; 111(11):2102-8. PubMed ID: 15522378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
    Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-induced ptosis: case studies and histopathologic analysis.
    Song A; Carter KD; Nerad JA; Boldt C; Folk J
    Eye (Lond); 2008 Apr; 22(4):491-5. PubMed ID: 17220825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior sub-Tenon's capsule triamcinolone.
    Pal N; Azad RV
    Ophthalmology; 2006 Mar; 113(3):504-5; author reply 505. PubMed ID: 16513471
    [No Abstract]   [Full Text] [Related]  

  • 13. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema.
    Tunc M; Onder HI; Kaya M
    Ophthalmology; 2005 Jun; 112(6):1086-91. PubMed ID: 15885789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection.
    Kovacs K; Wagley S; Quirk MT; Ceron OM; Silva PA; Singh RJ; Gukasyan HJ; Arroyo JG
    Am J Ophthalmol; 2012 May; 153(5):939-48. PubMed ID: 22310078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intractable glaucoma after a single low-dose sub-Tenon's corticosteroid injection for macular edema.
    Levy J; Tessler Z; Klemperer I; Lifshitz T
    Can J Ophthalmol; 2004 Oct; 39(6):672-3. PubMed ID: 15559656
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
    Moshfeghi AA; Scott IU; Flynn HW; Puliafito CA
    Am J Ophthalmol; 2004 Sep; 138(3):489-92. PubMed ID: 15364241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vision loss and vascular compromise with facial and periocular injections.
    Li B; Allen LH; Sheidow TG
    Can J Ophthalmol; 2015 Aug; 50(4):e57-60. PubMed ID: 26257235
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse events after intravitreal triamcinolone in patients with and without uveitis.
    Galor A; Margolis R; Brasil OM; Perez VL; Kaiser PK; Sears JE; Lowder CY; Smith SD
    Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.